Skip to content

Screening and Access to Health Care for Vascular Disease

Screening and Access to Health Care for Vascular Disease in Urban and Suburban Patient Populations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01889485
Enrollment
190
Registered
2013-06-28
Start date
2014-06-01
Completion date
2021-05-31
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Abdominal, Carotid Stenosis, Peripheral Arterial Disease

Keywords

Aortic Aneurysm, Abdominal, Carotid Stenosis, Peripheral Arterial Disease, Health Services Accessibility

Brief summary

This is a pilot study designed to validate our methods of recruitment, screening and data collection in the community. The project will help to establish the feasibility of the study design to lay the groundwork for a potentially larger study. The final study will allow us to estimate the incidence and prevalence of abdominal aortic aneurysm (AAA), carotid artery stenosis, and peripheral artery disease (PAD) in different geographic areas in a large urban setting, as well as determine patient access to healthcare and treatment for vascular disease as related to geographic and racial differences.

Interventions

None listed

Sponsors

Medtronic
CollaboratorINDUSTRY
Endeavor Health
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age 55 or older * willing/able to provide consent * willing to participate in follow-up phone calls at defined intervals for up to 5 years

Exclusion criteria

* unable to provide consent to participate * unwilling/unable to participate in the follow-up phone call

Design outcomes

Primary

MeasureTime frame
Geographic and racial differences in access to follow-up care if significant disease is identified through the screening event5 years

Secondary

MeasureTime frame
Geographical and racial differences in patterns of accessing healthcare prior to the screening events.1 year
Differences in rates of interventions throughout the 5 year follow-up period.5 years
Differences in the rates of complications related to treatment of vascular disease in the various geographic areas in which the events are held.5 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026